HG/T 5539-2019
HG/T 5539-2019
H-acid monosodium salt(1-Naphthylamine-8-hydroxy-3,6-disulfonic acid monosodium salt)
HG/T 5539-2019
铁矿石 锡含量的测定 邻苯二酚紫-溴化十六烷基三甲胺分光光度法
HG/T 5539-2019
1-Amino-8-hydroxy-3,6-naphthalenedisulfonic acid monosodium salt(H-acid monosodium salt)
HG/T 5539-2019
H-acid monosodium salt(1-Amino-8-hydroxy-3,6-naphthalenedisulfonic acid monosodium salt)
HG/T 5539-2019
HG/T 5539-2019
Commission Regulation (EU) 2017/171 of 30 January 2017 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for aminopyralid, azoxystrobin, cyantraniliprole, cyflufenamid, cyproconazole, diethofencarb, dithiocarbamates, fluazifop-P, fluopyram, haloxyfop, isofetamid, metalaxyl, prohexadione, propaquizafop, pyrimethanil, Trichoderma atroviride strain SC1 and z
HG/T 5539-2019
HG/T 5539-2019
HG/T 5539-2019
HG/T 5539-2019
Commission Implementing Regulation (EU) 2019/707 of 7 May 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, for
HG/T 5539-2019
Commission Implementing Regulation (EU) 2018/1796 of 20 November 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, bifenox, chlorpyrifos, chlorpyrifos-methyl, clofentezine, dicamba, difenoconazole, diflubenzuron, diflufenican, dimoxystrobin, fenoxaprop-p, fenpropidin, lenacil, mancozeb, mecoprop-p, metiram, nicosulfuron, oxamyl, picloram, pyraclostrobin